AAAAAA

   
Results: 1-12 |
Results: 12
Costs of diagnosis, treatment, and follow up of patients with acute myeloid leukemia in the Netherlands
Authors: Uyl-de Groot, CA Hartog, JGD Huijgens, PC Willemze, R Van Ineveld, BM
Citation: Ca. Uyl-de Groot et al., Costs of diagnosis, treatment, and follow up of patients with acute myeloid leukemia in the Netherlands, J HEMATH ST, 10(1), 2001, pp. 187-192
Quality of life of patients with refractory chronic rhinosinusitis: Effects of filgrastim treatment
Authors: van Agthoven, M Fokkens, WJ van de Merwe, JP van Bolhuis, EM Uyl-de Groot, CA Busschbach, JJV
Citation: M. Van Agthoven et al., Quality of life of patients with refractory chronic rhinosinusitis: Effects of filgrastim treatment, AM J RHINOL, 15(4), 2001, pp. 231-237
The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up
Authors: van Agthoven, M van Ineveld, BM de Boer, MF Leemans, CR Knegt, PP Snow, GB Uyl-de Groot, CA
Citation: M. Van Agthoven et al., The costs of head and neck oncology: primary tumours, recurrent tumours and long-term follow-up, EUR J CANC, 37(17), 2001, pp. 2204-2211
Cost analysis and quality of life assessment comparing patients undergoingautologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease: a prospective randomised trial
Authors: van Agthoven, M Vellenga, E Fibbe, WE Kingma, T Uyl-de Groot, CA
Citation: M. Van Agthoven et al., Cost analysis and quality of life assessment comparing patients undergoingautologous peripheral blood stem cell transplantation or autologous bone marrow transplantation for refractory or relapsed non-Hodgkin's lymphoma or Hodgkin's disease: a prospective randomised trial, EUR J CANC, 37(14), 2001, pp. 1781-1789
A cost-utility analysis comparing second-line chemotherapy schemes in patients with metastatic breast cancer
Authors: Li, N van Agthoven, M Willemse, PHB Uyl-de Groot, CA
Citation: N. Li et al., A cost-utility analysis comparing second-line chemotherapy schemes in patients with metastatic breast cancer, ANTI-CANC D, 12(6), 2001, pp. 533-540
Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study
Authors: Vellenga, E van Agthoven, M Croockewit, AJ Verdonck, LF Wijermans, PJ van Oers, MHJ Volkers, CP van Imhoff, GW Kingma, T Uyl-de Groot, CA Fibbe, WE
Citation: E. Vellenga et al., Autologous peripheral blood stem cell transplantation in patients with relapsed lymphoma results in accelerated haematopoietic reconstitution, improved quality of life and cost reduction compared with bone marrow transplantation: the Hovon 22 study, BR J HAEM, 114(2), 2001, pp. 319-326
Economics and health-related quality of life in antiemetic therapy: recommendations for trial design
Authors: Uyl-de Groot, CA Wait, S Buijt, I
Citation: Ca. Uyl-de Groot et al., Economics and health-related quality of life in antiemetic therapy: recommendations for trial design, EUR J CANC, 36(12), 2000, pp. 1522-1535
Costs of peripheral blood progenitor cell transplantation using whole blood mobilised by filgrastim as compared with autologous bone marrow transplantation in non-Hodgkin's lymphoma
Authors: Uyl-de Groot, CA Ossenkoppele, GJ Buijt, I Huijgens, PC
Citation: Ca. Uyl-de Groot et al., Costs of peripheral blood progenitor cell transplantation using whole blood mobilised by filgrastim as compared with autologous bone marrow transplantation in non-Hodgkin's lymphoma, PHARMACOECO, 15(3), 1999, pp. 305-311
Cost of care in a randomised trial of early hospital discharge after surgery for breast cancer
Authors: Bonnema, J van Wersch, AMEA van Geel, AN Pruyn, JFA Schmitz, PIM Uyl-de Groot, CA Wiggers, T
Citation: J. Bonnema et al., Cost of care in a randomised trial of early hospital discharge after surgery for breast cancer, EUR J CANC, 34(13), 1998, pp. 2015-2020
Special issue - Economic evaluation of cancer treatments
Authors: Uyl-de Groot, CA
Citation: Ca. Uyl-de Groot, Special issue - Economic evaluation of cancer treatments, ANTI-CANC D, 9(10), 1998, pp. 833-833
Economic evaluation of cancer treatments: methodological and practical issues
Authors: Uyl-de Groot, CA Touw, CKR
Citation: Ca. Uyl-de Groot et Ckr. Touw, Economic evaluation of cancer treatments: methodological and practical issues, ANTI-CANC D, 9(10), 1998, pp. 835-841
Costs of intensive treatment and follow-up of patients with multiple myeloma
Authors: Buijt, I Ossenkoppele, GJ Uyl-de Groot, CA Huijgens, PC
Citation: I. Buijt et al., Costs of intensive treatment and follow-up of patients with multiple myeloma, ANTI-CANC D, 9(10), 1998, pp. 889-897
Risultati: 1-12 |